These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21742481)

  • 1. Are drug detection dogs and mass-media campaigns likely to be effective policy responses to psychostimulant use and related harm? Results from an agent-based simulation model.
    Dray A; Perez P; Moore D; Dietze P; Bammer G; Jenkinson R; Siokou C; Green R; Hudson SL; Maher L
    Int J Drug Policy; 2012 Mar; 23(2):148-53. PubMed ID: 21742481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SimAmph: an agent-based simulation model for exploring the use of psychostimulants and related harm amongst young Australians.
    Perez P; Dray A; Moore D; Dietze P; Bammer G; Jenkinson R; Siokou C; Green R; Hudson SL; Maher L
    Int J Drug Policy; 2012 Jan; 23(1):62-71. PubMed ID: 21715152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending drug ethno-epidemiology using agent-based modelling.
    Moore D; Dray A; Green R; Hudson SL; Jenkinson R; Siokou C; Perez P; Bammer G; Maher L; Dietze P
    Addiction; 2009 Dec; 104(12):1991-7. PubMed ID: 19804460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of drug detection dogs in Sydney, Australia.
    Dunn M; Degenhardt L
    Drug Alcohol Rev; 2009 Nov; 28(6):658-62. PubMed ID: 19930020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Street-level policing in the Downtown Eastside of Vancouver, Canada, during the 2010 Winter Olympics.
    Small W; Krusi A; Wood E; Montaner J; Kerr T
    Int J Drug Policy; 2012 Mar; 23(2):128-33. PubMed ID: 21885271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based policy or policy-based evidence? The role of evidence in the development and implementation of the Illicit Drug Diversion Initiative.
    Hughes CE
    Drug Alcohol Rev; 2007 Jul; 26(4):363-8. PubMed ID: 17564871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heroin-assisted treatment in Switzerland: a case study in policy change.
    Uchtenhagen A
    Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The size and mix of government spending on illicit drug policy in Australia.
    Moore TJ
    Drug Alcohol Rev; 2008 Jul; 27(4):404-13. PubMed ID: 18584391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal timing of use reduction vs. harm reduction in a drug epidemic model.
    Caulkins JP; Tragler G; Wallner D
    Int J Drug Policy; 2009 Nov; 20(6):480-7. PubMed ID: 19361975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of drug prevention system development in Romania and its impact on youth drug consumption trends, 1995-2005.
    Dégi CL
    Drug Alcohol Rev; 2009 Jul; 28(4):419-25. PubMed ID: 19594796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. If supply-oriented drug policy is broken, can harm reduction help fix it? Melding disciplines and methods to advance international drug-control policy.
    Greenfield VA; Paoli L
    Int J Drug Policy; 2012 Jan; 23(1):6-15. PubMed ID: 21689918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of joined-up HIV harm reduction and multidrug resistant tuberculosis control programmes in Estonia: System dynamics simulation model.
    Atun RA; Lebcir RM; McKee M; Habicht J; Coker RJ
    Health Policy; 2007 May; 81(2-3):207-17. PubMed ID: 16854499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of law enforcement and substitution treatment on heroin mortality.
    Nordt C; Stohler R
    Drug Alcohol Rev; 2010 Sep; 29(5):540-5. PubMed ID: 20887578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Policy and the Public Good: a summary of the book.
    Drugs and Public Policy Group
    Addiction; 2010 Jul; 105(7):1137-45. PubMed ID: 20642498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Casting light on harm reduction: introducing two instruments for analysing contradictions between harm reduction and 'non-harm reduction'.
    Jourdan M
    Int J Drug Policy; 2009 Nov; 20(6):514-20. PubMed ID: 19349155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain medicine and drug law enforcement: an important step toward balance.
    Joranson DE; Portenoy RK
    J Pain Palliat Care Pharmacother; 2005; 19(1):3-5. PubMed ID: 15814508
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug policing, harm reduction and health: directions for advocacy.
    Burris S; Burrows D
    Int J Drug Policy; 2009 Jul; 20(4):293-5. PubMed ID: 19403297
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress to achieve balanced state policy relevant to pain management and palliative care: 2000-2003.
    Gilson AM; Joranson DE; Maurer MA; Ryan KM; Garthwaite JP
    J Pain Palliat Care Pharmacother; 2005; 19(1):13-26. PubMed ID: 15814511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.